Top Markets
#1 Helium Helium +108.34%
#2 MowCat MowCat +101.34%
#3 Seeker Seeker +77.99%
#4 AI XOVIA AI XOVIA +45.07%
#5 Pons Pons +39.63%
#6 UnifAI Network UnifAI Network +33.66%
#7 Bounce Bounce +32.28%
#8 Tensor Tensor +23.04%
#9 Zylo Ecosystem Zylo Ecosystem +21.68%
#10 pipedog pipedog +21.23%
Coin of the day
Helium Helium
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Kedudukan dalam Saham #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Harga Saham
$8.74
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$699.74M
Perubahan (1 hari)
-4.85%
Perubahan (1 tahun)
-2.29%
Negara
US
Perdagangan BridgeBio Oncology Therapeutics Inc. (BBOT)

Kategori

Healthcare
Sejarah dividen untuk BridgeBio Oncology Therapeutics Inc. (BBOT)
BridgeBio Oncology Therapeutics Inc. (simbol saham: BBOT) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk BridgeBio Oncology Therapeutics Inc. (BBOT) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
Tidak cukup data untuk tarikh yang disediakan.
Senarai semua pembayaran dividen
Tahun Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH